Bleximenib in combination with intensive chemotherapy: A phase 1b study in newly diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 alterationsHartmut Döhner, Andrew H. Wei, Alicia J. Allred et al.|Blood|2025Cited by 10
Phase 1b study of bleximenib in combination with venetoclax in Acute Myeloid Leukemia with KMT2A or NPM1 alterationsJenny O’Nions, Sylvain Garciaz, Andrew H. Wei et al.|Blood|2025Cited by 4
8th Canadian Immunization Conference Sheraton Centre Hotel, Toronto, Ontario November 30 to December 3, 2008J Bettinger, Louise Valiquette, David W. Scheifele et al.|Europe PMC (PubMed Central)|2008Cited by 0